Shinobi Therapeutics

About:

Shinobi Therapeutics develops immune-evasive iPS cell therapies for cancer treatment.

Website: https://www.shinobitx.com

Top Investors: F-Prime Capital, Mitsubishi UFJ Capital, EQT Life Sciences, JIC Venture Growth Investments, Eight Roads Ventures Japan

Description:

Shinobi Therapeutics focuses on creating hypoimmune CD8αβ iPS-T cells that work with the immune system to treat cancer and other diseases. The company utilizes advanced immune evasion technology to enhance the effectiveness and accessibility of cell therapies. Shinobi's innovative approach aims to reduce costs and improve patient outcomes through durable responses and redosing capabilities.